WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ:ALTH) announced today the pricing of an underwritten public offering of 7,750,000 shares of its common stock. The Company expects the offering to close on or about April 3, 2009, subject to customary closing conditions.
